SEC Tracker
Get the app

Rocket Pharmaceuticals RCKT

John Militello (Officer) plans to sell 284 RCKT shares, about $4,394

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Aug 17, 2023
  2. Broker: Fidelity Brokerage Services LLC
  3. Shares acquired by: Restricted Stock Vesting

All of John Militello's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 284 shares at $15.47 on Aug 17, 2023 ยท Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Rocket Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Perspective Therapeutics CATX public float $213M, Jun 30, 2025
  2. Natures Sunshine Products NATR public float $211M, Jun 30, 2025
  3. Tvardi Therapeutics TVRD public float $207M, Jun 30, 2025
  4. SELLAS Life Sciences Group SLS public float $219M, Jun 30, 2025
  5. Precigen PGEN public float $219M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.